thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q26829652-097742A8-14B7-4054-89DF-E4D96A5E8960
Q26829652-097742A8-14B7-4054-89DF-E4D96A5E8960
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26829652-097742A8-14B7-4054-89DF-E4D96A5E8960
Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies
P2860
Q26829652-097742A8-14B7-4054-89DF-E4D96A5E8960
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26829652-097742A8-14B7-4054-89DF-E4D96A5E8960
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
af17ba0c34d501bcc94f99c2f1c2da6c57a4c5c4
P2860
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies.